• Aug 26, 2026

  $107.06-2.07%

  Comparable listed companies in Biological Products fell -0.55% on average, with 4 of 6 declining [1]. HALO fell 2.07%, a somewhat larger move in the same direction as the broader peer group.

  • 1Peer group

• Aug 25, 2026

  $109.32+0.63%

  Comparable listed companies in Biological Products rose +3.07% on average, with 5 of 6 advancing [1]. HALO's gain of 0.63% was in the same direction but considerably smaller than the peer group's move.

  • 1Peer group

• Aug 24, 2026

  $108.64+0.43%

  Comparable listed companies in Biological Products fell -0.97% on average, with 2 of 6 declining [1]. HALO rose 0.43%, moving against the peer group's overall direction on the day.

  • 1Peer group

• Aug 21, 2026

  $108.17+1.93%

  Comparable listed companies in Biological Products rose +1.71% on average, with 5 of 6 advancing [1]. HALO rose 1.93%, broadly in line with the peer group, on volume of 0.5x its trailing 20-session average [2].

  • 1Peer group
  • 2Market data

• Aug 20, 2026

  $106.12-1.39%

  Comparable listed companies in Biological Products fell -1.36% on average, with 5 of 6 declining [1]. HALO fell 1.39%, consistent with the broad move across the peer group.

  • 1Peer group

• Aug 19, 2026

  $107.62+2.60%

  Comparable listed companies in Biological Products rose +7.55% on average, with all 6 advancing [1]. HALO rose 2.60%, in the same direction as the peer group though by a smaller margin.

  • 1Peer group

• Aug 18, 2026

  $104.89+1.83%

  Comparable listed companies in Biological Products fell -1.61% on average, with 5 of 6 declining [1]. HALO rose 1.83%, moving in the opposite direction from the majority of the peer group on the day.

  • 1Peer group

Closing prices for HALO. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.